Monoamine oxidase (MAOA) inhibitors could help researchers develop prostate cancer treatments -- ScienceDaily

The study, published in the Journal of Clinical Investigation,
found that suppressing the enzyme monoamine oxidase A, or MAOA, may
reduce or even eliminate prostate tumor growth and metastasis in
laboratory mice. The finding could open the door for physicians to use
antidepressants to fight prostate cancer. Currently, drugs that inhibit
MAOA enzymes are used to treat patients with mental illnesses like
depression.

No comments: